We are live on
!
Find out more
LCG
Lisanti Capital Growth Portfolio holdings
AUM
$397M
1-Year Est. Return
178.66%
This Fund
S&P 500
This Quarter
Est. Return
+15.69%
1 Year Est. Return
+178.66%
3 Year Est. Return
+1,089.72%
5 Year Est. Return
+3,176.57%
10 Year Est. Return
+120,936.2%
AUM
$95.2M
AUM Growth
-$15.8M
(-14%)
Cap. Flow
-$23.2M
Cap. Flow
% of AUM
-24.35%
Top 10 Holdings %
Top 10 Hldgs %
20.01%
Holding
124
New
37
Increased
15
Reduced
36
Closed
35
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Healthcare Services Group
HCSG
|
+$1.51M |
| 2 |
Tyler Technologies
TYL
|
+$1.49M |
| 3 |
Steris
STE
|
+$1.44M |
| 4 |
Pacira BioSciences
PCRX
|
+$1.36M |
| 5 |
Commault Systems
CVLT
|
+$1.26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ABMD
Abiomed Inc
ABMD
|
+$1.98M |
| 2 |
Axos Financial
AX
|
+$1.83M |
| 3 |
RDUS
Radius Health, Inc.
RDUS
|
+$1.75M |
| 4 |
Molina Healthcare
MOH
|
+$1.65M |
| 5 |
PGTI
PGT, Inc.
PGTI
|
+$1.62M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.67% |
| 2 | Healthcare | 25.31% |
| 3 | Consumer Discretionary | 15.48% |
| 4 | Industrials | 11.43% |
| 5 | Financials | 5.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EFII
51
DELISTED
Electronics for Imaging
EFII
| $998K | 1.05% |
+21,352
| New | +$1.01M |
|
|
LOGM
52
DELISTED
LogMein, Inc.
LOGM
| $992K | 1.04% |
14,777
-23,240
| -61% | -$1.62M |
|
|
DPLO
53
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $987K | 1.04% |
28,837
+13,454
| +87% | +$420K |
|
54
Dycom Industries
DY
$12B
| $979K | 1.03% |
13,987
-2,078
| -13% | -$165K |
|
|
TWOU
55
DELISTED
2U Inc
TWOU
| $970K | 1.02% |
1,156
-458
| -28% | -$343K |
|
56
Diamondback Energy
FANG
$57.1B
| $961K | 1.01% |
14,370
+1,010
| +8% | +$75.1K |
|
57
Paycom
PAYC
$7.64B
| $960K | 1.01% |
25,505
-24,328
| -49% | -$975K |
|
58
Skywest
SKYW
$4.24B
| $921K | 0.97% |
48,420
-53,880
| -53% | -$1.05M |
|
|
MSCC
59
DELISTED
Microsemi Corp
MSCC
| $901K | 0.95% |
+27,646
| New | +$975K |
|
|
IPHI
60
DELISTED
INPHI CORPORATION
IPHI
| $856K | 0.9% |
31,693
-16,734
| -35% | -$479K |
|
61
Kforce
KFRC
$1.02B
| $849K | 0.89% |
33,570
-40,375
| -55% | -$1.07M |
|
|
CYNO
62
DELISTED
Cynosure, Inc. Class A
CYNO
| $828K | 0.87% |
+18,542
| New | +$704K |
|
|
KTWO
63
DELISTED
K2M Group Holdings, Inc
KTWO
| $791K | 0.83% |
+40,073
| New | +$779K |
|
64
HealthEquity
HQY
$8.41B
| $728K | 0.76% |
29,035
+8,575
| +42% | +$263K |
|
|
PRAH
65
DELISTED
PRA Health Sciences, Inc.
PRAH
| $689K | 0.72% |
+15,215
| New | +$639K |
|
66
Blackbaud
BLKB
$1.94B
| $685K | 0.72% |
+10,400
| New | +$650K |
|
|
LNCE
67
DELISTED
Snyders-Lance, Inc.
LNCE
| $679K | 0.71% |
+19,809
| New | +$716K |
|
|
CEMP
68
DELISTED
Cempra, Inc.
CEMP
| $624K | 0.66% |
+20,045
| New | +$558K |
|
69
Inogen
INGN
$175M
| $621K | 0.65% |
15,502
-19,754
| -56% | -$835K |
|
70
Motorcar Parts of America
MPAA
$254M
| $608K | 0.64% |
+17,993
| New | +$643K |
|
71
Burlington
BURL
$23.2B
| $593K | 0.62% |
13,832
-9,352
| -40% | -$433K |
|
72
Acadia Healthcare
ACHC
$2.76B
| $570K | 0.6% |
9,130
-10,486
| -53% | -$683K |
|
73
AppFolio
APPF
$6.38B
| $549K | 0.58% |
37,572
-24,329
| -39% | -$408K |
|
74
Halozyme
HALO
$9.79B
| $519K | 0.55% |
+29,963
| New | +$478K |
|
75
Acadia Pharmaceuticals
ACAD
$4.43B
| $510K | 0.54% |
14,293
-4,892
| -25% | -$172K |
|
Similar funds
GF
PIM
EH
TPWA
ECA
DL
STT
VC
Lisanti Capital Growth's Q4 2015 Portfolio in Review
As of Q4 2015, Lisanti Capital Growth held 124 positions worth $95.2M, down 14% from $111M the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Lisanti Capital Growth withdrew a net $23.2M in Q4 2015, closing 35 positions and reducing 36 holdings. Its most notable exit was Abiomed Inc, an estimated $1.98M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Lisanti Capital Growth opened a new position in Healthcare Services Group worth $1.45M.
- Lisanti Capital Growth's largest Q4 2015 buy was Healthcare Services Group: 41,616 shares worth $1.45M.
- Lisanti Capital Growth added most to Opus Bank Common Stock in Q4 2015, an estimated $853K increase.
- Lisanti Capital Growth's biggest Q4 2015 reduction was LogMein, Inc., cutting an estimated $1.62M.
- Lisanti Capital Growth fully exited Abiomed Inc in Q4 2015, selling an estimated $1.98M.
- Lisanti Capital Growth's ten largest holdings make up 20% of its $95.2M portfolio in Q4 2015.
- Lisanti Capital Growth opened 37 new positions and closed 35 in Q4 2015.
- Lisanti Capital Growth's portfolio value fell 14% quarter-over-quarter to $95.2M.
Based on Lisanti Capital Growth's 13F filing for Q4 2015, filed 5 Feb 2016.